Cetera Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $428K | Buy |
+169,317
| New | +$428K | ﹤0.01% | 1702 |
|
|
2023
Q4 | – | Sell |
-125,112
| Closed | -$425K | – | 1804 |
|
|
2023
Q3 | $425K | Buy |
125,112
+63,774
| +104% | +$217K | 0.01% | 1147 |
|
|
2023
Q2 | $451K | Buy |
61,338
+50,457
| +464% | +$371K | 0.01% | 1116 |
|
|
2023
Q1 | $113K | Buy |
+10,881
| New | +$113K | ﹤0.01% | 1551 |
|
|
2020
Q4 | – | Sell |
-8,379
| Closed | -$866K | – | 1041 |
|
|
2020
Q3 | $866K | Buy |
8,379
+106
| +1% | +$11K | 0.03% | 407 |
|
|
2020
Q2 | $654K | Buy |
8,273
+3,436
| +71% | +$272K | 0.03% | 466 |
|
|
2020
Q1 | $280K | Buy |
+4,837
| New | +$280K | 0.02% | 613 |
|